Pieris Pharmaceuticals In... (PIRS)
NASDAQ: PIRS
· Real-Time Price · USD
13.60
-2.51 (-15.58%)
At close: Dec 13, 2024, 10:00 PM
Pieris Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | -53K | n/a | 1.35M | 20.87M | 40.93M | 42.81M | 47.36M | 33.21M | 16.85M | 25.9M | 28.5M | 27.19M | 26.77M | 31.42M | 24.85M | 23.73M | 31.7M |
Cost of Revenue | 1.47M | 1.44M | 5.17M | 5.91M | 5.89M | 6.49M | 2.62M | 2.65M | 13.88M | 14.14M | 14.15M | 32.31M | 36.16M | 51.89M | 61.92M | 54.8M | 50.34M |
Gross Profit | -83K | n/a | -3.82M | 14.96M | 35.04M | 36.32M | 44.74M | 30.55M | 2.98M | 11.76M | 14.35M | -5.13M | -9.39M | -20.47M | -37.06M | -31.07M | -18.64M |
Operating Income | 5.3M | n/a | -18.1M | -26.77M | -20.53M | -30.74M | -36.77M | -37.13M | -51.53M | -43.47M | -42.95M | -49.8M | -54.23M | -51.83M | -53.24M | -47.23M | -35.12M |
Interest Income | -240K | n/a | 1.06M | 1.45M | 1.73M | 1.85M | 1.75M | 1.44M | 1.08M | 724K | 373K | 136K | 7K | 10K | 18K | 69K | 195K |
Pretax Income | -20.73M | -17.43M | -15.95M | -23.82M | -16.25M | -24.54M | -28.06M | -27.05M | -41.36M | -33.28M | -34.71M | -41.51M | -46.67M | -45.74M | -50.44M | -48.19M | -37.64M |
Net Income | -20.73M | -17.43M | -15.95M | -23.82M | -16.25M | -23.67M | -27.16M | -24.94M | -39.26M | -29.69M | -30.77M | -38.78M | -43.94M | -45.37M | -50.61M | -48.35M | -37.8M |
Selling & General & Admin | 16M | 16.35M | 13.47M | 16.73M | 16.97M | 16.85M | 18.51M | 15.62M | 16.04M | 16.39M | 16.49M | 16.68M | 16.84M | 16.59M | 16.18M | 16.16M | 16.48M |
Research & Development | 10.98M | 8.15M | 6.01M | 16.05M | 29.63M | 41.8M | 50.73M | 54.72M | 52.34M | 52.98M | 54.96M | 60.31M | 64.16M | 66.66M | 61.92M | 54.8M | 50.34M |
Other Expenses | n/a | n/a | 15.6M | 16.1M | 15.94M | 13.91M | -5.07M | -7.05M | -6.21M | -6.31M | -4.02M | -1.87M | -2.08M | 931K | 193K | -1.82M | -2.71M |
Operating Expenses | 26.98M | 24.5M | 19.48M | 32.78M | 45.01M | 55.04M | 62.23M | 61.87M | 60.31M | 61.2M | 65.58M | 70.78M | 75.19M | 79.56M | 75.5M | 70.17M | 66.82M |
Interest Expense | -5.1M | -3.89M | 2.33M | 2.33M | 2.33M | 2.33M | n/a | n/a | n/a | 3K | 9K | 9K | 9K | 6K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.83M | 25.19M | 19.45M | 32.75M | 44.98M | 55.04M | 62.23M | 61.87M | 60.31M | 61.2M | 65.58M | 70.78M | 75.19M | 79.56M | 75.5M | 70.17M | 66.82M |
Income Tax Expense | 73.28K | 73.28K | -699K | -699K | -699K | -1.57M | -897K | -2.1M | -2.1M | -3.59M | -3.93M | -2.73M | -2.73M | -372K | 1.99M | 1.99M | 1.99M |
Shares Outstanding (Basic) | 110.14K | 2.23M | 1.32M | 1.3M | 1.24M | 1.24M | 1.24M | 1.1M | 931.49K | 930.6K | 929.96K | 925.68K | 921.39K | 901.64K | 846.63K | 773.81K | 703.71K |
Shares Outstanding (Diluted) | 110.14K | 2.23M | 1.32M | 1.3M | 1.24M | 1.24M | 1.24M | 1.1M | 931.49K | 930.6K | 929.96K | 925.68K | 921.39K | 901.64K | 846.63K | 773.81K | 703.71K |
EPS (Basic) | -78.2 | -7.83 | -12.61 | -19.12 | -12.73 | -22 | -26.97 | -27.44 | -42.24 | -32 | -33.48 | -43.84 | -52.7 | -55.65 | -66.06 | -67.56 | -55.09 |
EPS (Diluted) | -78.2 | -7.83 | -12.61 | -19.12 | -12.73 | -22 | -26.97 | -27.44 | -42.24 | -32 | -33.48 | -43.84 | -52.7 | -55.65 | -66.06 | -67.56 | -55.09 |
EBITDA | -17.16M | -22.46M | -17.2M | -10.24M | -1.36M | -8.67M | -11.6M | -24.39M | -38.86M | -30.5M | -32.26M | -39.25M | -44.39M | -44.56M | -47.01M | -43.31M | -32.57M |
EBIT | 5.3M | n/a | -17.2M | -10.98M | -4.74M | -12.92M | -16.44M | -30.22M | -43.43M | -35.05M | -36.85M | -43.37M | -48.19M | -48.15M | -50.65M | -46.43M | -35.12M |
Depreciation & Amortization | 30K | n/a | 446K | 1.19M | 1.91M | 2.51M | 2.62M | 2.65M | 2.5M | 2.77M | 2.77M | 2.59M | 2.61M | 2.37M | 2.39M | 2.3M | 2.19M |